PerPlexity Biotechnology Profile - TipRanks - PerPlexity Analyst
39 Followers
PerPlexity Biotechnology's Stock Coverage
| ZURAZura Bio | Nov 17, 2026 | SELL | Reiterated | $1.00 | 68Ratings | +23.10% | ||
| ZNTLZentalis Pharmaceuticals | Nov 17, 2026 | SELL | Reiterated | $1.50 | 82Ratings | +6.90% | ||
| YARWYarrow Bioscience | Nov 17, 2026 | SELL | Downgraded | $13.00 | 63Ratings | +22.70% | ||
| XCURExicure | Nov 17, 2026 | SELL | Downgraded | $1.00 | 96Ratings | +0.90% | ||
| XBIOXenetic Biosciences | Nov 17, 2026 | HOLD | Reiterated | $1.50 | 74Ratings | ― | ― | |
| WVEWave Life Sciences | Nov 17, 2026 | HOLD | Reiterated | $3.00 | 60Ratings | ― | ― | |
| VYGRVoyager Therapeutics | Nov 17, 2026 | HOLD | Upgraded | $1.50 | 47Ratings | +14.80% | ||
| VTVTvTv Therapeutics | Nov 17, 2026 | HOLD | Upgraded | $17.50 | 63Ratings | +10.70% | ||
| VRCAVerrica Pharmaceuticals | Nov 17, 2026 | HOLD | Reiterated | $3.00 | 99Ratings | ― | ― | |
| VANIVivani Medical | Nov 17, 2026 | HOLD | Reiterated | $0.97 | 36Ratings | ― | ― |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >PerPlexity Biotechnology activity FAQ
What is the performance of PerPlexity Biotechnology's recommendations?
The percentage of profitable recommendations made by PerPlexity Biotechnology is 61.87%, and the average return per transaction is 5.60%.
What stocks does PerPlexity Biotechnology cover?
PerPlexity Biotechnology mostly covers Ascentage Pharma Group International Unsponsored ADR, AbCellera Biologics, Abeona Therapeutics stocks.
What was PerPlexity Biotechnology's most profitable rating?
PerPlexity Biotechnology’s most profitable rating was a sell on Tessera Defense and Homeland Security stock on Nov 05, 2026. The return on the trade was 82.20%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here
